|
Statements of Operations and Comprehensive Loss (Unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified |
3 Months Ended | |
|---|---|---|
|
Mar. 31, 2015
|
Mar. 31, 2014
|
|
| Revenues: | ||
| Development revenues | $ 4,349 | $ 6,800 |
| Commercial revenues | 657 | 1,404 |
| Total revenues | 5,006 | 8,204 |
| Operating expenses: | ||
| Cost of commercial revenues | 84 | 101 |
| Research, development and patents | 6,403 | 7,017 |
| Selling, general and administrative | 3,096 | 3,102 |
| Total operating expenses | 9,583 | 10,220 |
| Loss from operations | (4,577) | (2,016) |
| Other income | 8 | 8 |
| Net loss | (4,569) | (2,008) |
| Other comprehensive income (loss): | ||
| Unrealized gain (loss) on investments | 10 | 1 |
| Comprehensive loss | $ (4,559) | $ (2,007) |
| Net loss per share, basic and diluted (in dollars per share) | $ (0.11) | $ (0.05) |
| Shares used in calculating net loss per share, basic and diluted (in shares) | 43,499,650 | 41,466,762 |